In March 2008, in a pre-emptive move, Merck announced that its allergy/asthma drug, Singulair, might cause some people to act on suicidal thoughts. They didn't have any scientific evidence yet, but anecdotal evidence from patients had been coming in. The risk was serious enough that they felt they should let the public know. However, the FDA decided not to take it off the market or even issue a black box warning until the issue could be studied more closely.
Over the past few months, that's...
Did you see the reports last week that Singulair was going to be investigated by the Food and Drug Administration for reports of a "casual... Read more »
Asthma is a disease that affects over 5% of Americans, many of which are infants and young children. This entry will discuss asthma and... Read more »
Even during my short lifespan the definition of asthma has changed quite a bit. It's important we asthmatics keep up on the current... Read more »
Being a gallant asthmatic means more than simply taking all your medicines compliantly and having an Asthma Action Plan. It also involves... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
